Assistant Professor of Pediatrics, Boston Children's Hospital
Pediatric Hematology & Oncology
Dr. Matthew M. Heeney, MD
|
|
Give Review
Dr. Matthew M. Heeney works in the field of Pediatric Hematology & Oncology. He received awards:"Fellow (FAAP)". Doctor Matthew M. Heeney, MD is a published doctor. He published 42 publications, including: 'Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing...'
Publications
- Congenital sideroblastic Anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.
- Prasugrel in Children With Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Data From an Open-label, Adaptive-design, Dose-ranging Study.
- Clinical outcomes of splenectomy in children: Report of the splenectomy in congenital hemolytic Anemia registry.
- Mutations in TRNT1, encoding the CCA-adding enzyme, cause congenital sideroblastic Anemia with B cell immunodeficiency, periodic fevers and developmental delay (SIFD).
- Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell Anemia: results from the SWiTCH trial.
- X-linked sideroblastic Anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations.
- Bacteremia risk and outpatient management of febrile patients with Sickle cell disease.
- Platelet Activation and Inhibition iN Sickle cell disease (PAINS) study.
- Weight Status of Children With Sickle Cell Disease.
- Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S.
- Thirty-day readmission rates following hospitalization for pediatric Sickle cell crisis at freestanding children's hospitals: Risk factors and hospital variation.
- Transition from pediatric to adult care for Sickle cell disease: results of a survey of pediatric providers.
- Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with Sickle cell disease.
- Encephalopathy from lead poisoning masquerading as a flu-like syndrome in an autistic child.
- High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine.
- Resolution of cerebral artery stenosis in a child with sickle cell Anemia treated with hydroxyurea.
- Hydroxyurea for children with Sickle cell disease.
- Corticosteroids for acute chest syndrome in children with Sickle cell disease: variation in use and association with length of stay and readmission.
- Clinical practice guideline improves the treatment of Sickle cell disease vasoocclusive pain.
- Cefepime-induced Neutropenia in a teenager.
- Mutations in TMPRSS6 cause iron-refractory iron deficiency Anemia (IRIDA).
- Preventing stroke among children with sickle cell Anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.
- Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and response.
- Hemoglobin SE Disease: a concise review.
- Acquired Immune cytopenias post-cardiac transplantation respond to rituximab.
- Iron homeostasis and inherited iron overload Disorders: an overview.
- Chemical and functional analysis of hydroxyurea oral solutions.
- Childhood autoImmune cytopenia secondary to unsuspected common variable immunodeficiency.
- UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell Anemia.
- Increased expression of anti-apoptosis genes in peripheral blood Cells from patients with paroxysmal nocturnal hemoglobinuria.
- Interpretation of fetal hemoglobin only on newborn screening for hemoglobinopathy.
- Sickle cell detection using a smartphone.
- Hemoglobinopathies mimicking Hb S/beta-Thalassemia: Hb S/S with alpha-Thalassemia and Hb S/Volga.
- Chronic transfusion practice for children with Sickle cell anaemia and stroke.
- Pial synangiosis in patients with moyamoya syndrome and sickle cell Anemia: perioperative management and surgical outcome.
- Risk of cholelithiasis in sickle cell Anemia.
- Common variants at 10 genomic loci influence hemoglobin Aâ(C) levels via glycemic and nonglycemic pathways.
- Definitions of the phenotypic manifestations of Sickle cell disease.
- Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicen...
- A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
- Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with Sickle cell anaemia-TCD With Transfusions Changing...
Schools
University Of Calgary Faculty Of Medicine
Montreal Children39s Hospital
Duke University
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Hypercoagulable State
- Immune Thrombocytopenic Purpura (ITP)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Fellow (FAAP)
Education
-
Duke University Hospital -
University of Calgary Faculty of Medicine
Hospital
-
Brigham and Women's Hospital -
Boston Children's Hospital -
Dana-Farber Cancer Institute
Helpful Reviews
Similar Doctors
|
|
Dr. Cameron C. Trenor III, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akiko Shimamura, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. Sartain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey Rubens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison Friedmann, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrew L. Kung, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Esther A. Obeng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cathy G. Rosenfield, MD
This Doctor is OpenDoctor Recommended.
|